ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2593

The Prognosis Of Scleroderma Renal Crisis In RNA-Polymerase III Antibody (ARA) Positive Compared To ARA Negative Patients

Bernadette Lynch1, Henry Penn2, Jennifer Harvey3, Aine Burns4 and Christopher P. Denton5, 1Department of Rheumatology, The Royal Free Hospital, London, United Kingdom, 2Northwick Park Hospital, Harrow, United Kingdom, 3Clinical Immunology, Royal Free Hospital, London, United Kingdom, 4Department of Nephrology, The Royal Free Hospital, London, United Kingdom, 5Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, London, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Antibodies, hypertension, renal disease and scleroderma

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Session Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s - Clinical Aspects and Therapeutics II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Scleroderma renal crisis (SRC) usually presenting with accelerated hypertension and acute kidney injury (AKI) is one of the most severe complications of Systemic Sclerosis (SSc). The presence of RNA-polymerase III auto-antibodies (ARA) is recognized as a strong risk factor for SRC but studies have not explored long-term outcomes in ARA positive cases compared to ARA negative cases.

Methods:

Of more than 2000 SSc patients attending our institution between 1990-2013, 150 patients had a confirmed SRC. 80% patients had diffuse cutaneous SSc (dcSSc) and 20% patients had limited cutaneous SSc (dcSSc). ARA was measured by commercial ELISA or radio-immuno-precipitation. Patients were divided into two groups: ARA positive or ARA negative. Demographic and clinical parameters were compared between groups using Student’s t-test or Chi-squared analyses where appropriate.

Results:

61/150 (41%) patients were ARA positive and significantly more likely to have dcSSc (88.3% vs 73.8%, p=0.032) than lcSSc compared to ARA negative patients. There was no significant difference in age of onset of SRC (51.2 vs 51.9 years) or the number of females (73% vs 79%) between the two groups. 50.8% of ARA positive patients required dialysis compared to 29.2% of ARA negative patients (p=0.07). The mean time to recovery of renal function was significantly longer in ARA positive patients (14.25 vs 8.27 months, p=0.032). Significantly more ARA positive patients were able to discontinue dialysis compared to ARA negative patients (53.3% vs 25.5%, p=0.01). ARA positive patients had a significantly better survival outcome (figure 1).

Conclusion:

In SRC, although more ARA positive patients required dialysis they also had significantly greater capacity for long-term recovery and survival compared to ARA negative patients.

Figure 1: Kaplan Meier survival estimate showing the effect of ARA positive auto-antibodies in patients with SRC


Disclosure:

B. Lynch,
None;

H. Penn,
None;

J. Harvey,
None;

A. Burns,
None;

C. P. Denton,
None.

  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-prognosis-of-scleroderma-renal-crisis-in-rna-polymerase-iii-antibody-ara-positive-compared-to-ara-negative-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.